Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Viridian Therapeutics, Inc.\De Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $846 Billion
- Q2 2025
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 423,272 shares of VRDN stock, worth $9.45 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
423,272
Previous 423,272
-0.0%
Holding current value
$9.45 Million
Previous $5.71 Billion
3.71%
% of portfolio
0.7%
Previous 1.18%
Shares
2 transactions
Others Institutions Holding VRDN
# of Institutions
184Shares Held
83MCall Options Held
78.9KPut Options Held
417K-
Deep Track Capital, LP Greenwich, CT5.38MShares$120 Million2.67% of portfolio
-
Commodore Capital LP New York, NY4.88MShares$109 Million6.35% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$107 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$101 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.43MShares$98.8 Million7.39% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $890M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...